Bybit Introduces Global Credit Incentive for TradFi Platform Adoption
DUBAI, UAE, Aug. 1, 2025 /PRNewswire/ --Â Bybit, the world's second-largest cryptocurrency exchange…
CORRECTION Sony Joins the AR Alliance to Advance the Future of Augmented Reality Wearable Devices
The following press release corrects information previously announced by AR Alliance on July 31,…
adidas and Liverpool FC Launch New Home and Away Jerseys for the 2025/26 Season
New 2025/26 Home jersey expresses the club’s DNA in its purest form…
Landmark Trial Demonstrates Efficacy of Microcurrent Therapy in Heart Failure: C-MIC II Results Published in the European Journal of Heart Failure
ZUG, Switzerland, July 23, 2025 /PRNewswire/ -- Berlin Heals and the C-MIC II…
Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders
June 20, 2025 17:00 ET Â | Source: Inozyme Pharma Inc. BOSTON, June…
Hexagon launches AEON, a humanoid built for industry
Hexagon leverages industry-leading expertise in measurement technologies, AI and autonomous systems to…
Draganfly Announces Additional Exercise Of Over-Allotment Option
Saskatoon, SK., June 06, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO)…
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 05, 2025 16:58 ET Â | Source: Boundless Bio, Inc. SAN DIEGO,…
ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)
June 05, 2025 16:31 ET  | Source: ImPact Biotech – Previously inoperable…
OHI Group S.A. Announces Consent Solicitation Relating to its U.S.$400,000,000 13.000% Senior Secured Amortizing Notes due 2029 Regulation S Notes: CUSIP L7S61M AB5, ISIN USL7S61MAB59 Rule 144A Notes: CUSIP 67712M AB5, ISIN US67712MAB54 (the “Notes”)
Executive Summary — As previously announced, OHI Group S.A. (the "Issuer") is preparing…